®
®
New York, New York, May 1, 2007, Bio-Organic Catalyst, Inc. and Neozyme International Inc., subsidiaries of International Daleco Corporation (OTC Bulletin Board: ILDO) today announced that they have been successfully treating hydrogen sulfide (H2S) odors within a municipal collection system located in Connecticut on a commercial basis. NEW YORK, NEW YORK, MAY 1, 2007, Bio-Organic Catalyst, Inc. and Neozyme International Inc., subsidiaries of International Daleco Corporation (OTC Bulletin Board: ILDO) today announced that they have been successfully treating hydrogen sulfide (H2S) odors within a municipal collection system located in Connecticut on a commercial basis.
These H2S odors had historically been measured at levels over 350 parts per million (ppm), and were a continuing source of community complaints. After installation of a metered dosing system, where the Company’s bio-organic catalyst was added on a continuous basis, H2S odors were substantially reduced to levels of less than 1.0 ppm. Successfully solving the odor problems at less cost than traditional chemical additives.
The Company’s revolutionary technology breakthrough approaches the solution of reducing dangerous and noxious odors, such as H2S gas formation, in a fundamentally different way from conventional chemical additives, which simply treat the wastewater within the collection system.
The Company’s bio-organic catalysts break down the anaerobic slime layers, which form within the collection system pipes, thereby treating the problem of eliminating odors within collection systems ‘at source’, where they are formed prior to migration to the wastewater within the sewer pipes.
Additionally, the Company’s bio-organic catalysts also bring about a substantial increase in dissolved oxygen levels within the wastewater stream through the action of micro-bubbles which are formed by the bio-organic catalysts, thereby bringing the required oxidation to sulfides within the wastewater.
Another valuable advancement, in addition to the elimination of noxious and dangerous odors, is that the Company’s bio-organic catalysts have shown the ability to cause a reduction of the organic loading of the wastewater in the collection system, prior to the municipal wastewater treatment facility.
This technological solution has tremendous implications to the upgrading of collection systems worldwide, particularly in the developing world. Through utilizing the collection system to reduce the wastewater’s organic loading, the wastewater treatment facility’s total loading capacity is increased. This can offset capital expansion requirements and also improve the performance of the facility in reducing discharges and sludge volumes.
About Bio-Organic Catalyst, Inc.:
Bio-Organic Catalyst, Inc. is a wholly-owned subsidiary of Neozyme International, Inc. It has been formed as the proprietary branding entity for commercialization of the Company’s bio-organic catalyst compositions. It has trademarked ‘Bio-Organic Catalyst’ as a unique category within the emerging green chemistry field. This fundamental advancement over traditional and green chemistries, where the waste contaminants are catalytically broken down to their fundamental constituents and the receiving waters have their dissolved oxygen levels increased, represents a major technical breakthrough with substantial implications across many industries; including water and wastewater treatment, green cleaning for industrial, commercial and consumer markets, and the cleaning and accelerated bio-remediation of petroleum hydrocarbon pollutants.
About Neozyme International, Inc.:
Neozyme International, Inc. is the Company’s research and development entity, which over the last decade funded the research and applications development of a line of patented and proprietary bio-organic catalysts. Representing a fundamentally new and different model for treating both wastewater and solid wastes, it has been necessary to exhaustively test and demonstrate the capabilities of the Company’s bio-organic catalysts within a wide variety of laboratory and field applications. Additionally, economic modeling, demonstrating competitive advantages over competing chemistries, has been required to establish market introductions.
About International Daleco Corporation:
International Daleco Corporation (OTC Bulletin Board: ILDO) is a publicly quoted venture capital firm with over 25 years of experience in funding the development of new technologies. Over the past decade, the Company has primarily focused on the development of patented and proprietary bio-organic catalysts. In addition to this development effort, the Company has interests in other technology companies in the environmental monitoring and medical diagnostic fields.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Statements in this news release looking forward in time involve risks and uncertainties, including the risks associated with the effect of changing economic conditions, trends in the products markets, variations in the Company's cash flow, market acceptance risks, patent litigation, technical development risks, seasonality and other risk factors detailed in the company's Securities and Exchange Commission filings.
This News Release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based largely on the Company’s expectations of forecasts of future events, can be affected by inaccurate assumptions and are subject to various risks and known and unknown uncertainties, a number of which are beyond the Company’s control. Therefore, actual results could differ materially from the forward-looking statements herein.
Home|SiteMap|Company|FAQs|Technology|Applications|Products|Connect|News|Links